Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 12Neoplasms 11Brain Neoplasms 10Lung Neoplasms 9Glioma 9Glioblastoma 9Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Rectal Neoplasms 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Colonic Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Cancer, Papillary 2Small Cell Lung Carcinoma 2Recurrence 2Oligodendroglioma 2Neurotoxicity Syndromes 2Neuroendocrine Tumors 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myeloid, Acute 2

Interventions

Radiomics 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pancreatic Ductal Adenocarcinoma × Magnetic Resonance Spectroscopy × Clear all
NCT06600906 2025-11-12

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

University of California, San Francisco

Recruiting
70 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡